Rothfuss Cristin 4
4 · Sarepta Therapeutics, Inc. · Filed Dec 2, 2025
Insider Transaction Report
Form 4
Rothfuss Cristin
EVP, General Counsel
Transactions
- Tax Payment
Common Stock
2025-11-28$21.12/sh−229$4,836→ 139,756 total
Footnotes (1)
- [F1]Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 26, 2024.